Management Team


WWiKY is managed by experts in a range of relevant scientific and clinical fields including oncology, radiotherapy, drug development, and pharmacology. In addition, executive team members also possess experience in commercialization, clinical trials, regulatory and medical affairs, and drug manufacturing.

Dr. Piyush Kumar, PhD

President, Chief Executive Officer

Dr. MiCHAEL Weinfeld, PhD

Vice President & Chief Scientific Officer

Dr. John Yao, PhD

Chief Financial Officer

Jyoti Tailor, MBA, Msc

Vice President: Business

Advisory Board

Dr. Leonard I. Wiebe, PhD, DSc.

Adjunct Professor, Oncology, University of Alberta, Edmonton; Experience: Tumor
Hypoxia, Radiopharmaceuticals

Dr. Michael Sawyer, DM, FRCP

Medical Oncologist, Cross Cancer Institute; Experience: Clinical Lead on the WWiKY Biosciences Inc. sponsored Phase I/II Cancer clinical trial

 

Dr. Naresh Jha, MD

Radiation Oncologist, Cross Cancer Institute; Experience: Radiotherapy, Head & Neck Cancers; Collaborator on the WWiKY Biosciences Inc. sponsored Phase I/II Cancer clinical trial

Dr. Sharon Barker, PhD

Experience: Investment and Financial Advisor Johnson & Johnson, Canada, Ex- CEO WWiKY Biosciences Inc., Edmonton

Collaborators

Prof. Ravin Narain

A Chemical and Biomedical Engineer that is collaborating with WWiKY BioSciences on the development of bioreductively-activated nanotheranostics’ pipeline